Cargando…
Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease
Neovascular eye diseases include conditions such as retinopathy of prematurity, proliferative diabetic retinopathy, and neovascular age-related macular degeneration. Together, they are a major cause of vision loss and blindness worldwide. The current therapeutic mainstay for these diseases is intrav...
Autores principales: | Muniyandi, Anbukkarasi, Hartman, Gabriella D., Song, Yang, Mijit, Mahmut, Kelley, Mark R., Corson, Timothy W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Pharmacology and Experimental Therapeutics
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289243/ https://www.ncbi.nlm.nih.gov/pubmed/37142441 http://dx.doi.org/10.1124/jpet.122.001563 |
Ejemplares similares
-
Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells
por: Mijit, Mahmut, et al.
Publicado: (2023) -
An improved method for murine laser-induced choroidal neovascularization lesion quantification from optical coherence tomography images
por: Jensen, Nathan R., et al.
Publicado: (2022) -
Retinal Phenotyping of Ferrochelatase Mutant Mice Reveals Protoporphyrin Accumulation and Reduced Neovascular Response
por: Sardar Pasha, S. P. B., et al.
Publicado: (2021) -
APE1/Ref-1 as a Novel Target for Retinal Diseases
por: Heisel, Curtis, et al.
Publicado: (2021) -
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
por: Murukesh, N, et al.
Publicado: (2010)